Trial intelligence / Profile preview

Tetrabenazine for Huntington's Chorea

NCT00219804Phase 3Completed

Sponsor
Prestwick Pharmaceuticals
Modality
Small Molecules
01

Overview

A Phase 3 trial of tetrabenazine in Huntington's disease (HD), sponsored by Prestwick Pharmaceuticals. Status: completed.

02

Drugs

tetrabenazine
03

Conditions

Huntington's disease (HD)

Beyond the preview

Go deeper on NCT00219804.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00219804.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call